The sex hormone profile of male patients with breast cancer
Open Access
- 1 September 1983
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 48 (3) , 423-427
- https://doi.org/10.1038/bjc.1983.208
Abstract
The mean total serum oestradiol level was found to be significantly increased in 8 patients with carcinoma of the breast when compared with 8 healthy reference subjects matched for race, sex and age. The calculated mean free oestradiol index was also higher in these patients. There were no significant differences, however, between the levels of LH, FSH, prolactin. DHEA-S, testosterone and SHGB in the 2 groups. The patients showed a significantly increased LH response to GnRH while there was no difference in the FSH response. Only 1/7 patients had a tumour devoid of steroid hormone receptors. It may be that an increased level of circulating oestradiol-17 beta is an important factor in the aetiology of hormone-dependent male breast cancer.Keywords
This publication has 16 references indexed in Scilit:
- CYTOPLASMIC AND NUCLEAR ESTROGEN AND PROGESTERONE RECEPTORS IN MALE BREAST-CANCER1982
- Hormone receptors in male breast carcinomaJournal of Surgical Oncology, 1981
- NUCLEAR AND CYTOPLASMIC ESTROGEN-RECEPTORS IN HUMAN MAMMARY-CARCINOMA1980
- CLINICAL CORRELATIONS OF STEROID-RECEPTORS AND MALE BREAST-CANCER1980
- Plasma estrogens and androgens in male breast cancerThe Journal of Steroid Biochemistry and Molecular Biology, 1976
- The role of orchiectomy in the management of advanced male breast cancerCancer, 1976
- Prolactin and Breast CarcinomaNew England Journal of Medicine, 1975
- A rapid method for the measurement of sex hormone binding globulin capacity of seraClinica Chimica Acta; International Journal of Clinical Chemistry, 1974
- Immunological and Karyological Criteria for Identification of Cell Lines2JNCI Journal of the National Cancer Institute, 1960
- The treatment of cancer, especially inoperable cancer, of the male breast by ablative surgey (orchiectomy, adrenalectomy, and hypophysectomy) and hormone therapy (estrogens and corticosteroids).An analysis of 42 patientsCancer, 1959